Cartesian Therapeutics (RNAC) Prepaid Assets (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Prepaid Assets of $3.1 million for Q1 2026, up 7.39% year-over-year from $2.9 million in Q1 2025, and up 3.81% quarter-over-quarter from $3.0 million in Q4 2025.
Cartesian Therapeutics (RNAC) Prepaid Assets (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Prepaid Assets for 12 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 7.39% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (up 7.39% YoY), while the FY2025 annual figure was $3.0 million, down 3.88% from the prior year.
- Prepaid Assets climbed to $3.1 million in Q1 2026 per RNAC's latest filing, from $3.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $6.5 million in Q2 2022 and bottomed at $2.0 million in Q2 2024.
- Historically, Prepaid Assets has averaged $3.9 million across 5 years, with a median of $3.5 million in 2023.
- Annual changes were most pronounced in 2024 — Prepaid Assets plunged 52.0% — and 2025, when it soared 32.93%.
- Cartesian Therapeutics' Prepaid Assets stood at $3.8 million in 2022, then surged by 31.47% to $5.0 million in 2023, then plunged by 36.7% to $3.1 million in 2024, then fell by 3.88% to $3.0 million in 2025, then climbed by 3.81% to $3.1 million in 2026.
- Business Quant data shows RNAC's Prepaid Assets at $3.1 million in Q1 2026, $3.0 million in Q4 2025, and $3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.81 Mn |
| Mar 31, 2026 | 3.14 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 3.15 Mn |
| Jun 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 2.92 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 3.32 Mn |
| Dec 31, 2023 | 4.97 Mn |
| Sep 30, 2023 | 3.49 Mn |
| Jun 30, 2023 | 4.26 Mn |
| Mar 31, 2023 | 3.79 Mn |
| Dec 31, 2022 | 3.78 Mn |
| Sep 30, 2022 | 6.31 Mn |
| Jun 30, 2022 | 6.52 Mn |
| Mar 31, 2022 | 5.42 Mn |
| Dec 31, 2021 | 6.47 Mn |
| Sep 30, 2021 | 5.78 Mn |